Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:27:51.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section listing Louisville, Kentucky as the study site; removed the Kentucky Locations entry and HHS Vulnerability Disclosure; updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:42.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.2, replacing the prior v3.2.0; this is a minor UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:20:42.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Removed a general operating-status notice about government funding and NIH operations, which does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:47:20.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The study contact information was updated: Marilyn Donaldson was removed as contact and Robert Martin, MD, PhD is now listed with updated phone and email. Primary Completion is now estimated for 2028-06-01 and Study Completion for 2029-04-01, and a new 'Last Update Posted (Estimated)' indicator was added.
    Difference
    1%
    Check dated 2025-11-03T13:19:36.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.
    Difference
    6%
    Check dated 2025-10-06T04:16:01.000Z thumbnail image

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.